TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 0 | -5 | -9 | -14 | -26 | -46 | -17 |
| S | %wins | 67 | 100 | 100 | 100 | 67 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/08 17:25 | 2/4/08 | AMLN | Amylin Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Graham Ginger L | CA | D | S | -29 | 31.98 | 33 | -1 | -1 | 148 | D | -20 | -22 | -37 | -27 | -18 | -11 | -4 | 6 | 0 | -5 | -19 | -7 | 2 | -58 | |
8/8/07 18:33 | 8/8/07 | AMLN | Amylin Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Graham Ginger L | CA | O | Exec Adv | S.d | -1,184 | 51.46 | 33 | -23 | -13 | 148 | D | 153 | 6 | 25 | 22 | 26 | 17 | 8 | 7 | 0 | -6 | -5 | -20 | -41 | -40 |
8/7/07 20:58 | 8/6/07 | AMLN | Amylin Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Graham Ginger L | CA | O | Exec Adv | S.dm | -1,000 | 50.01 | 33 | -20 | -12 | 148 | D | 130 | 1 | 23 | 19 | 21 | 15 | 4 | 6 | 1 | -4 | -2 | -15 | -39 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |